Quantcast

Latest SNP array Stories

2013-12-12 23:28:26

ACOG and ACMG issue new guidelines supporting the utilization of cytogenomic microarray analysis as appropriate diagnostic testing for prenatal, postnatal, infertility and oncology samples. Stony Brook, NY (PRWEB) December 12, 2013 CytoGenX Corp, a leading provider of medical genetic testing services, announced today it will be offering Assure™, its new comprehensive whole-genome microarray designed to aid in the detection and identification of disease-causing genetic alterations...

2011-03-15 00:00:27

Affymetrix, Inc. (NASDAQ: AFFX) today launched the Affymetrix® SNP 6 Core Reagent Kit, a comprehensive workflow solution that provides pre-mixed and validated reagents for nearly every step in the SNP 6.0 assay. This convenient kit eliminates the need for mixing tedious buffers, reduces the need to order from multiple vendors, and enables easier inventory management with a single kit expiration date. Santa Clara, CA (Vocus/PRWEB) March 14, 2011 Affymetrix, Inc. (NASDAQ: AFFX) today...

2011-01-04 03:57:23

Technique leverages gene-dense data chip for new discoveries As much as 90 percent of variation in adult height may be caused by genetic inheritance, but a multitude of genes are involved. Most of these have yet to be discovered. Now a new meta-analysis of data from more than 100,000 people has identified variants in over two dozen genes that were not previously associated with height. The study also confirmed genetic associations in more than 30 previously known height genes. "Although the...

2010-12-31 12:23:59

A large collaborative study has added to the growing list of genetic variants that determine how tall a person will be. The research, published by Cell Press on December 30 in the American Journal of Human Genetics, identifies uncommon and previously unknown variants associated with height and might provide insight into the genetic architecture of other complex traits. Although environmental variables can impact attained adult height, it is clear that height is primarily determined by...

2009-08-14 12:26:15

Researchers at the Keck School of Medicine of the University of Southern California (USC) have identified a novel genetic mechanism that may govern an individual's risk of developing prostate cancer.The findings, published today in the Public Library of Science (PLoS) Genetics journal, found mechanisms involved in cancer-associated sites in areas where no genes are present (gene 'deserts') at a chromosomal region called 8q24. The new findings show that some of these sites have embedded...

2009-05-15 13:13:00

OMAHA, Neb., May 15 /PRNewswire/ -- Creighton Medical Laboratories, based at Creighton University School of Medicine in Omaha, announced today that it has become the first clinical laboratory worldwide to offer a new and more effective testing method for cancer. The method, called SNP array karyotyping, has been successfully used in research laboratories to study cancer for several years. However, Creighton Medical Laboratories, using AffymetrixTM SNP arrays, is the first laboratory to...

2008-10-23 18:00:25

Affymetrix Inc., (Nasdaq:AFFX) today reported its operating results for the third quarter of 2008. Total revenue for the quarter was $75.2 million, as compared to total revenue of $95.0 million in the third quarter of 2007. Product revenue was $66.0 million, which consists of array and reagent revenue of $59.8 million and instrument revenue of $6.2 million. Service revenue was $6.1 million, and royalties and other revenue were $3.1 million for the third quarter of 2008. This compares to...

2008-10-07 09:00:56

Affymetrix Inc., (Nasdaq:AFFX) today announced that one of South Africa's largest public core labs has begun offering genomic research on the Affymetrix GeneChip(R) platform. The Centre for Proteomic and Genomic Research (CPGR) is using many Affymetrix GeneChip arrays, such as the exon array and the SNP Array 6.0, to explore applications with molecular diagnostics potential, large-scale genotyping and novel ways of advancing drug research and development across the country. The CPGR...

2008-09-25 09:00:54

Affymetrix Inc. (Nasdaq:AFFX) announced today that the Wellcome Trust Sanger Institute has developed a catalog of structural genomic changes in almost 800 cancer cell lines using the company's Genome-Wide Human SNP Array 6.0. Cancer cell lines are invaluable reagents in analyzing the molecular biology of the disease as well as important tools in developing new healing methods. The core set of cancer cell lines developed by the Cancer Genome Project includes samples from most types of...

2008-08-13 09:01:15

Affymetrix Inc. (Nasdaq:AFFX) announced today that researchers around the world have used the Affymetrix Genome-Wide Human SNP Arrays 5.0 and 6.0 to uncover important links between copy number variations (CNVs) and schizophrenia. Researchers from the United States, Europe and Asia published their findings in recent issues of Nature and Nature Genetics. Schizophrenia is a chronic and disabling disorder that affects 2.4 million Americans alone. Even with the best treatments currently...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related